Page 104 - 85 cell signalling pathways
P. 104

Cell Signalling Biology Michael J. Berridge  Module 2  Cell Signalling Pathways               2  104




             Module 2: Figure JAK/STAT function
                                   Agonist




                                         P     P     P        P    P         P   P        P
                                     JAK
                                                        P  P           P  P         P  P
                                 1          2
                                                                    4
                                                                                   _
                                                         3
                                SH2 domain
                                                STAT               5
                                DNA-binding                            P P
                                 domain
                                                                                     SOCS
                                      CRM1     Export             Import    Importin

                                                  8               6
                                                                           Importin
                                       CRM1
                                                  N-PTP               Target genes
                                                                        SOCS
                                                          P P                   7

             The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) activation cascade.
             A schematic summary of the main sequence of events responsible for the activation of signal transducers and activators of transcription (STATs).
             Agonist activation of cell-surface receptors induces dimerization of receptor subunits, resulting in the stimulation of resident Janus kinases (JAKs). The
             JAKs then carry out a sequential series of three phosphorylation reactions to activate the STATs, which then enter the nucleus to induce transcription.
             The binding between STATs and DNA is shown in Module 2: Figure STAT1/DNA complex .



             signalling pathways controlled by the TGF-β superfamily  Ligands
             have been associated with many cancers of epithelial and  The Smad signalling pathway is activated by a number of
             lymphoid origins, which fail to respond to the normal anti-  closely related ligands. The flagship ligand is transforming
             proliferative effects of TGF-β.The TGF-β receptor is one  growth factor β (TGF-β), but there are a number of other
             of the tumour suppressors that are switched off in many  ligands such as activin and nodal that also act through the
             cancers and particularly in colorectal cancer (CRC).  Smads (Module 2: Table Smad signalling toolkit). Nodal
               An increase in the expression of TGF-β1 may play a  has a role to play in establishing left-right asymmetry in
             critical role in the transition from stable hypertrophy to  the developing embryo.
             congestive heart failure (CHF).
                                                              Accessory receptors
             Smad signalling toolkit
                                                              These are cell-surface receptors that function as co-
             The Smad signalling pathway is made up from a large
                                                              receptors in that they promote the binding of the lig-
             number of components (Module 2: Table Smad signalling
                                                              ands to their signalling receptors. For example, the access-
             toolkit). Specific cell types express different combinations
                                                              ory receptor endoglin is essential for the action of activin
             of these components so that there is considerable variab-
                                                              receptor-like kinase 1 (ALK1) during the activation of an-
             ility in the nature of Smad signalling pathways. However,
                                                              giogenesis.
             the overall organization is fairly similar and is best ex-
             emplified by the action of transforming growth factor β
             (TGF-β) itself. The different components of the toolkit  TGF-β signalling receptors
             have been grouped together on the basis of their function  There are two groups of signalling receptors (Type I and II)
             in the signalling pathway (Module 2: Table Smad signalling  (Module 2: Table Smad signalling toolkit). These receptors
             toolkit):
                                                              contain a single membrane-spanning region that separates
                                                              the extracellular ligand-binding domain from the cytoso-
             Ligand traps                                     lic region that contains a serine/threonine kinase domain.
             These are a large group of proteins that control access  The Type I receptor also contains a glycine/serine-rich
             of the ligands to their cell-surface receptors. These ligand  (GS) domain, which is phosphorylated by the Type II re-
             traps can have an important inhibitory action since they  ceptor during the signal transduction process (as occurs
             can prevent the ligands from reaching their cell-surface  during the response to TGF-β Module 2: Figure TGF-βR
             receptors. For example, follistatin inhibits the action of  activation). Ligands act to complex these receptors so that
             activin on gonadotrophs (Module 10: Figure gonadotroph  the Type II can then activate the Type I, which in turn
             regulation).                                     activates the Smads (Module 2: Figure Smad signalling).




             C  2012 Portland Press Limited                                               www.cellsignallingbiology.org
   99   100   101   102   103   104   105   106   107   108   109